Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News International Isotopes Inc INIS

Technology Scientific & Technical Instruments
International Isotopes Inc. manufactures a range of radioisotope-focused products. The Company’s segments include Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Device Products, and Fluorine Products. The Theranostics Products segment includes production and distribution of its generic sodium iodide I-131 drug product for the treatment of hyperthyroidism and... see more

Recent & Breaking News (OTCQB:INIS)

INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2024

PR Newswire 10 days ago

International Isotopes Inc. and Phantech Medical Launch PhanQual to Revolutionize Calibration Sources for Pre-Clinical Imaging

PR Newswire September 4, 2024

INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE SECOND QUARTER AND FIRST SIX MONTHS OF 2024

PR Newswire August 15, 2024

INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE FIRST QUARTER OF 2024

PR Newswire May 16, 2024

INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR FISCAL YEAR 2023

PR Newswire April 1, 2024

INTERNATIONAL ISOTOPES TO DIVEST DEPLETED URANIUM DECONVERSION ASSETS TO AMERICAN FUEL RESOURCES FOR $12,500,000 CASH

PR Newswire February 8, 2024

INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2023

PR Newswire November 14, 2023

INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE SECOND QUARTER AND FIRST SIX MONTHS OF 2023

PR Newswire August 14, 2023

INTERNATIONAL ISOTOPES INC. ANNOUNCES CHANGES IN EXECUTIVE OFFICERS AND DIRECTORS

PR Newswire July 18, 2023

INTERNATIONAL ISOTOPES INC. ANNOUNCES THE ACQUISITION OF THE AMICI INC. PRODUCT LINE

PR Newswire June 21, 2023

INTERNATIONAL ISOTOPES INC. ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2023

PR Newswire May 16, 2023

INTERNATIONAL ISOTOPES INC. ANNOUNCES THE APPOINTMENT OF SHAHE BAGERDJIAN AS PRESIDENT

PR Newswire May 8, 2023

INTERNATIONAL ISOTOPES INC. ANNOUNCES 2022 YEAR END FINANCIAL RESULTS

PR Newswire April 6, 2023

INTERNATIONAL ISOTOPES INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE-MONTHS 2022

PR Newswire November 16, 2022

INTERNATIONAL ISOTOPES INC. ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER AND SIX MONTHS OF 2022

PR Newswire August 16, 2022

INTERNATIONAL ISOTOPES INC. ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2022

PR Newswire May 17, 2022

INTERNATIONAL ISOTOPES INC. ANNOUNCES 2021 YEAR END FINANCIAL RESULTS

PR Newswire April 4, 2022

INTERNATIONAL ISOTOPES INC. ANNOUNCES COMPLETION OF AN ASSET PURCHASE AGREEMENT WITH PHARMALOGIC HOLDINGS CORP.

PR Newswire February 22, 2022

INTERNATIONAL ISOTOPES INC. ANNOUNCES COMPLETION OF A MODIFICATION TO EXTEND THE MATURITY DATE OF ITS SERIES C PREFERRED STOCK

PR Newswire February 17, 2022

International Isotopes Inc. Announces Exclusive Licensing Agreement For Commercialization Of A Radiolabled Antibody Test For Detecting SARS CoV-2

PR Newswire December 7, 2021